Gene Mutations
Showing 1 - 25 of 9,107
Atypical Hemolytic Uremic Syndrome Trial in Ranica (Blood sampling and urine analysis)
Not yet recruiting
- Atypical Hemolytic Uremic Syndrome
- Blood sampling and urine analysis
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Mar 28, 2023
Cystic Fibrosis Trial in Richmond (Fitness tracker)
Not yet recruiting
- Cystic Fibrosis
- Fitness tracker
-
Richmond, VirginiaVirginia Commonwealth University
Jun 28, 2022
Pediatric Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations
Not yet recruiting
- Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)
- +2 more
- (no location specified)
Aug 25, 2023
Sensorineural Hearing Loss, Bilateral Trial in Philadelphia (AAVAnc80-hOTOF via Akouos Delivery Device)
Recruiting
- Sensorineural Hearing Loss, Bilateral
- AAVAnc80-hOTOF via Akouos Delivery Device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Apr 18, 2023
FGFR Gene Mutations in Tumor Tissue and Urine of Urothelial
Not yet recruiting
- Bladder Cancer
- FGFR test
- (no location specified)
Apr 6, 2022
Gene Mutations in Triple-negative and HER2+ Breast Cancer
Active, not recruiting
- Breast Cancer
-
Athens, GreeceGeorge Fountzilas
Mar 15, 2022
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)
Recruiting
- Renal Cell Carcinoma
- +4 more
-
Baltimore, MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022
Recurrent Glioblastoma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)
Recruiting
- Recurrent Glioblastoma
- Tislelizumab plus Bevacizumab
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Sep 11, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (Informational Intervention, Survey Administration)
Recruiting
- BRCA1 Gene Mutation
- BRCA2 Gene Mutation
- Informational Intervention
- Survey Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Mar 2, 2022
Assess Prevalence of Gene Mutations: Establishing Population
Recruiting
- Photoaging
- Mutation Burden
-
San Diego, CaliforniaWest Dermatology
Oct 14, 2021
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) Trial (DB-OTO)
Not yet recruiting
- Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
- DB-OTO
- (no location specified)
Mar 28, 2023
Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)
Not yet recruiting
- Metastatic Solid Tumor
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 12, 2023
Frequency of SOD1 and C9orf72 Gene Mutations in French ALS
Active, not recruiting
- Amyotrophic Lateral Sclerosis
- Blood
-
Angers, France
- +19 more
Jun 22, 2022
Drug Discovery for Parkinson's With Mutations in the GBA Gene
Recruiting
- Parkinson Disease
- +3 more
- Biological Sample Collection
-
New York, New YorkThe New York Stem Cell Foundation
Sep 7, 2022
Peripheral Nerves in Healthy Volunteers and Individuals With
Not yet recruiting
- PIEZO2-Deficiency Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 2, 2023
p53 and Response to Preoperative Radiotherapy for T2 and T3
Recruiting
- Rectal Cancer
- preoperative short course radiation
-
Vienna, AustriaMedical University of Vienna, Department of Surgery
Apr 6, 2022
Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)
Not yet recruiting
- Homozygous Familial Hypercholesterolemia
- NGGT006
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023
PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome Trial in Stanford, Boston, Cleveland (Sirolimus,
Not yet recruiting
- PTEN Gene Mutation
- +2 more
- Sirolimus
- Placebo
-
Stanford, California
- +2 more
Oct 5, 2023
Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)
Not yet recruiting
- Leber Hereditary Optic Neuropathy (LHON)
- NFS-02 Injection
- (no location specified)
Apr 6, 2023
Advanced Malignant Solid Tumor, Cholangiocarcinoma, Metastatic Malignant Solid Tumor Trial in Columbus (Infigratinib)
Recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 15, 2022
Trial
Not yet recruiting
- Leber Hereditary Optic Neuropathy (LHON)
- NR082 Injection
- Injection needle
- (no location specified)
Jan 30, 2023
HRR Prevalence in LatAm PROSPECT Study
Completed
- Castration-resistant Prostate Cancer
-
Ciudad Autónoma de Buenos Aires, Argentina
- +10 more
Apr 19, 2022